-

DXC TECHNOLOGY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against DXC Technology Company - DXC

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against DXC Technology Company (NYSE: DXC), if they purchased the Company’s shares between May 26, 2021, and May 16, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Virginia.

What You May Do

If you purchased shares of DXC and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-dxc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 1, 2024.

About the Lawsuit

DXC and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On May 16, 2024, the Company announced its results for the fourth quarter and full year for 2024, disclosing that “the previous restructurings did not set a real, clean, solid, fully integrated baseline for profitable growth” and that the Company was undertaking a “real reset” from the “bottom up” requiring an additional $250 million on increased restructuring expenses.

On this news, the price of DXC shares fell $3.36 per share, or nearly 17%, from a closing price of $19.88 per share on May 16, 2024, to a closing price of $16.52 per share on May 17, 2024.

The case is Roofers’ Pension Fund v. DXC Technology Company, No. 24-cv-1351.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana and New Jersey.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

Industry:

Kahn Swick & Foti, LLC

NYSE:DXC
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

More News From Kahn Swick & Foti, LLC

Talkspace Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Talkspace, Inc. - TALK

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Talkspace, Inc. (NasdaqCM: TALK) to Universal Health Services, Inc. (NYSE: UHS). Under the terms of the proposed transaction, shareholders of Talkspace will receive $5.25 in cash for each share of Talkspace that they own. KSF is seeking to determine whether this consideration and the process that le...

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NasdaqCM: SLNO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Soleno Therapeutics who were adversely affected by alleged securities fraud between March 26, 2025 and November 4, 2025. Follow th...

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims & Hers, disclosing that the Company had “failed to adhere to the law which prohibits mass sales of comp...
Back to Newsroom